Arthritis Foundation

Arthritis Foundation
Arthritis Foundation is listed in the Foundations Educational Philanthropic Research Etc category in Denver, Colorado. Displayed below are the social networks for Arthritis Foundation which include a Facebook page, a Instagram account, a Linkedin company page and a Twitter account. The activity and popularity of Arthritis Foundation on these social networks gives it a ZapScore of 90.

Contact information for Arthritis Foundation is:
2280 S Albion St
Denver, CO 80222
(303) 756-8622

"Arthritis Foundation" - ZapScore Report

Arthritis Foundation has an overall ZapScore of 90. This means that Arthritis Foundation has a higher ZapScore than 90% of all businesses on Zappenin. For reference, the median ZapScore for a business in Denver, Colorado is 38 and in the Foundations Educational Philanthropic Research Etc category is 46. Learn more about ZapScore

Do you own or manage this business? Click here to claim the Arthritis Foundation listing and add social networks, logos, descriptions and more.

Arthritis Foundation Contact Information:

Social Posts for Arthritis Foundation

Today is #GoutAwarenessDay! #Gout affects ~8.3M adults in the U.S. Get resources to help you deal with gout attacks:…

Have you seen the 500+ stories people have submitted to help us #FightFor50 during #ArthritisAwarenessMonth↠…

RT @opuscapitalmgmt: Proud of the #OpusTeam supporting the 2017 @ArthritisFdn Walk to Cure Arthritis! @CmnwealthOrtho @ChristHospital https…

@batman4600 @trutherbotred @ConspiracyWATCH That's a good tip, Dave! Thanks for sharing!

@NKaeding So happy to hear it, Nicole! Glad you could come out and join us! #WalkToCureArthritis

Arthritis Foundation shared Walk To Cure Arthritis's post.
We want to give a big THANK YOU to everyone who came out and joined us at a Walk To Cure Arthritis event this weekend! We hope you had as much fun as we did!
What a wonderful day full of Walk to Cure Arthritis events across the country. Thank you to each and everyone of you who helped make these events such a huge success!

The U.S. Food and Drug Administration (FDA) has approved Renflexis, a biosimilar to Remicade, making it the 4th biosimilar approved to treat inflammatory types of arthritis. Learn more about Renflexis and when it will be available below:
Renflexis is the second approved biosimilar to Remicade. The first one, Inflectra (infliximab-dyyb), was approved in April 2016. This is the first time the FDA has approved two biosimilars for one original, “reference” medication.

More than 50 million Americans have arthritis – that’s 1 in 4 people. But with your help, we're fighting back with our #FightFor50 campaign! Share your personal arthritis story and tell us why you fight. Check out the over 500 stories that have already been shared and consider donating today to help us conquer arthritis together!
Arthritis is currently the nation’s number one cause of disability. But this month—with your help— we’re fighting back with the #FightFor50 campaign! To participate, we are asking that you share your story — tell us about your person...

We're teaming up with our friends at Patient-Centered Outcomes Research Institute - PCORI for an online Q&A about the importance of patient-centered arthritis research! Mark your calendars and join us May 30 at 1 pm ET—we'll be taking your questions LIVE!
What does comparative effectiveness research offer patients with arthritis and their caregivers? Why is it important to get patients, caregivers, clinicians, and others involved in research? How will PCORI’s research help answer questions that empowe

This Arthritis Awareness Month, our friends at CVS Health are supporting our fight for the 50 million Americans with arthritis! This month, when you purchase Tylenol, Motrin, Advil or other select pain relief products, CVS Health will donate $1 to the Arthritis Foundation to support our mission!